PetCaseFinder

Peer-reviewed veterinary case report

Single joint injection options for hip arthritis in police dogs

By Alves, João C et al.·Published in Frontiers in veterinary science·2020·Divis&#xe3·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: A Pilot Study on the Efficacy of a Single Intra-Articular Administration of Triamcinolone Acetonide, Hyaluronan, and a Combination of Both for Clinical Management of Osteoarthritis in Police Working Dogs.

Species:
dog

Plain-English summary

A group of police working dogs with hip osteoarthritis (OA) received a single injection into their hip joints of either triamcinolone acetonide (a steroid), hyaluronan (a joint lubricant), or a combination of both. After treatment, many dogs showed significant improvements in pain and mobility over several months, particularly those that received the combination treatment. About 40% of the dogs treated with both medications experienced noticeable relief from pain. This suggests that using both treatments together can be an effective option for managing hip OA in dogs.

People also search for: dog hip osteoarthritis treatment · police dog joint pain · triamcinolone injection for dogs · hyaluronan for dog arthritis · combination therapy for dog osteoarthritis

Abstract

To describe and compare the use and effectiveness of a single intra-articular injection (IA) of triamcinolone acetonide (TA), hyaluronan (HA), and a combination of both (TA+HA) in police working dogs with natural occurring hip osteoarthritis (OA).Prospective, randomized, single-blinded study.Thirty animals with naturally occurring hip OA.Animals were randomly divided in three groups: GT, treated with 20 mg of TA per hip joint; GH, treated with treated 20 mg of HA per hip joint; and GTH, treated with a combination of 20 mg of TA and 20 mg of HA per hip joint. Response to treatment, measured by the Canine Brief Pain Inventory (divided in Pain Interference Score-PIS and Pain Severity Score-PSS) and the Hudson Visual Analog Scale (HVAS), was evaluated in seven different time points: T0 (before treatment), T1 (after 15 days), T2, T3, T4, T5, and T6 (after 1, 2, 3, 4, and 5 months, respectively). Results were compared using a Kruskal-Wallis test or a Wilcoxon signed ranks test, and< 0.05 was set.Comparing results of the different time points considered with T0, significant differences were registered in GH at T1 for HVAS (= 0.03) and PIS (= 0.04); and in GTH at T1 (= 0.05 for HVAS and< 0.05 for PIS), T2 (< 0.04 for PIS), T3 (< 0.03 for HVAS and= 0.05 for PIS), T4 (< 0.03 for HVAS and< 0.05), and T5 (< 0.05 for HVAS). No significant differences were found between groups when comparing scores in each time point. Individual treatment is considered successful with a reduction of &#x2265;1 for PSS or &#x2265;2 for PIS. In GTH, treatment was successful in four animals between T1 and T5 (40%,= 10) and three at T6-T7 (30%,= 10) for PSS and three animals of GTH at T1 (30%), two at T2 (20%), three between T3 and T4 (30%), and two between T5 and T7 (20%).This study provides direct information on the use of these treatment modalities in patients with hip OA. Intra-articular injection with TA and HA may be a treatment option for dogs with naturally occurring OA, particularly when simultaneously used, as they provide significant improvements of PIS and HVAS scores. Individual scores improved in some animals with PIS, PSS, and HVAS.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33282924/